These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19814747)

  • 81. Lessons learned from chemotherapeutic and immunosuppressant induced Hepatitis B reactivation - a case series.
    Nida' Ul-Huda A; Haniza O
    Med J Malaysia; 2021 Sep; 76(5):719-724. PubMed ID: 34508381
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy - A systematic review and meta-analysis.
    Maung ST; Deepan N; Decharatanachart P; Chaiteerakij R
    Asia Pac J Clin Oncol; 2024 Jun; 20(3):335-345. PubMed ID: 38512893
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Reactivation of HBV due to immunosuppressive and/or anticancer therapies].
    Mochida S
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():546-9. PubMed ID: 26845994
    [No Abstract]   [Full Text] [Related]  

  • 84. Hepatitis B virus infection in liver transplant candidates and recipients.
    Yachimski P; Chung RT
    MedGenMed; 2005 Apr; 7(2):20. PubMed ID: 16369399
    [No Abstract]   [Full Text] [Related]  

  • 85. Preventing hepatitis B reactivation due to immunosuppressive drug treatments.
    Perrillo RP; Martin P; Lok AS
    JAMA; 2015 Apr; 313(16):1617-8. PubMed ID: 25790287
    [No Abstract]   [Full Text] [Related]  

  • 86. [Report from Shikoku Chapter Educational Seminar: reactivation of hepatitis B virus].
    Tani J; Miyoshi H; Hosomi N; Yoneyama H; Izumikawa M; Maeda E
    Nihon Naika Gakkai Zasshi; 2014 Jun; 103(6):1397-405. PubMed ID: 25151807
    [No Abstract]   [Full Text] [Related]  

  • 87. Hepatitis B screening and vaccination practices in asian american primary care.
    Chu D; Yang JD; Lok AS; Tran T; Martins EB; Fagan E; Rousseau F; Kim WR
    Gut Liver; 2013 Jul; 7(4):450-7. PubMed ID: 23898386
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Universal hepatitis B virus screening in patients receiving immunosuppressive therapy: a small step for the oncologists, a major advance for prevention of hepatitis B virus reactivation.
    Roche B; Samuel D
    Clin Gastroenterol Hepatol; 2015 May; 13(5):976-8. PubMed ID: 25632804
    [No Abstract]   [Full Text] [Related]  

  • 89. Practice corner: should we screen all patients starting chemotherapy for chronic hepatitis B virus infection?
    McLachlan SA; De Cruz P
    Evid Based Med; 2009 Feb; 14(1):4. PubMed ID: 19181937
    [No Abstract]   [Full Text] [Related]  

  • 90. Evaluation and management of hepatitis B in pregnancy: a survey of current practices.
    Ahn J; Salem SB; Cohen SM
    Gastroenterol Hepatol (N Y); 2010 Sep; 6(9):570-8. PubMed ID: 21088746
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline].
    Cornberg M; Protzer U; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Sarrazin C; Dollinger MM; Schirmacher P; Dathe K; Kopp IB; Zeuzem S; Gerlich WH; Manns MP;
    Z Gastroenterol; 2011 Jul; 49(7):871-930. PubMed ID: 21748700
    [No Abstract]   [Full Text] [Related]  

  • 92. ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases.
    Zon RT; Neuss MN
    J Oncol Pract; 2010 Jul; 6(4):193-4. PubMed ID: 21037870
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The 2007 national practice benchmark: results of a national survey of oncology practices.
    Barr TR; Towle EL; Jordan WM
    J Oncol Pract; 2008 Jul; 4(4):178-83. PubMed ID: 20856769
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Benchmarking Practice Operations: Results From a Survey of Office-Based Oncology Practices.
    Akscin J; Barr TR; Towle EL
    J Oncol Pract; 2007 Jan; 3(1):9-12. PubMed ID: 29436910
    [No Abstract]   [Full Text] [Related]  

  • 95. HBV treatment in a patient who will be receiving immunosuppressive therapy.
    Feld JJ
    Clin Liver Dis (Hoboken); 2013 Feb; 2(1):34-37. PubMed ID: 30992818
    [No Abstract]   [Full Text] [Related]  

  • 96. Infectious disease screening in patients prior to undergoing immunosuppressive therapy.
    Sullivan R; Gaskell C; Lewis CR; Vollmer-Conna U; Post JJ
    Int J Clin Pract; 2019 Oct; 73(10):e13406. PubMed ID: 31441189
    [No Abstract]   [Full Text] [Related]  

  • 97. High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus.
    Chen MH; Wu CS; Chen MH; Tsai CY; Lee FY; Huang YH
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502025
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.
    Leber K; Otten HJMMB; Brandjes DPM; Claassen MAA; Lauw FN
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13495. PubMed ID: 34310787
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy.
    Wani MA; Sodhi JS; Yatoo GN; Shah A; Geelani S; Zargar SA; Gulzar GM; Khan M; Aziz SA
    J Clin Exp Hepatol; 2020; 10(6):590-598. PubMed ID: 33311896
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A survey of clinical practices among oncologists regarding hepatitis B screening in patients with cancer.
    Sundaram S; Patil P; Sengar M; Rathod R; Mehta S
    Indian J Med Res; 2020 Jun; 151(6):604-608. PubMed ID: 32719235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.